ENvue Medical Statistics
Total Valuation
ENvue Medical has a market cap or net worth of $5.29 million. The enterprise value is $4.27 million.
| Market Cap | 5.29M |
| Enterprise Value | 4.27M |
Important Dates
The last earnings date was Monday, May 18, 2026, after market close.
| Earnings Date | May 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENvue Medical has 6.09 million shares outstanding. The number of shares has increased by 3,835.78% in one year.
| Current Share Class | 6.09M |
| Shares Outstanding | 6.09M |
| Shares Change (YoY) | +3,835.78% |
| Shares Change (QoQ) | +198.65% |
| Owned by Insiders (%) | 3.94% |
| Owned by Institutions (%) | 1.21% |
| Float | 5.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.43 |
| Forward PS | n/a |
| PB Ratio | 0.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.90, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.90 |
| Quick Ratio | 0.43 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -543.76 |
Financial Efficiency
Return on equity (ROE) is -59.49% and return on invested capital (ROIC) is -23.34%.
| Return on Equity (ROE) | -59.49% |
| Return on Assets (ROA) | -20.23% |
| Return on Invested Capital (ROIC) | -23.34% |
| Return on Capital Employed (ROCE) | -41.19% |
| Weighted Average Cost of Capital (WACC) | 10.49% |
| Revenue Per Employee | $155,786 |
| Profits Per Employee | -$2.68M |
| Employee Count | 14 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 1.14 |
Taxes
| Income Tax | -289,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.64% in the last 52 weeks. The beta is 1.50, so ENvue Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | -91.64% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 3.36 |
| Relative Strength Index (RSI) | 31.62 |
| Average Volume (20 Days) | 856,142 |
Short Selling Information
The latest short interest is 163,391, so 2.68% of the outstanding shares have been sold short.
| Short Interest | 163,391 |
| Short Previous Month | 10,982 |
| Short % of Shares Out | 2.68% |
| Short % of Float | 2.79% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, ENvue Medical had revenue of $2.18 million and -$37.52 million in losses. Loss per share was -$26.15.
| Revenue | 2.18M |
| Gross Profit | -271,000 |
| Operating Income | -13.59M |
| Pretax Income | -20.42M |
| Net Income | -37.52M |
| EBITDA | -12.50M |
| EBIT | -13.59M |
| Loss Per Share | -$26.15 |
Balance Sheet
The company has $2.24 million in cash and $1.21 million in debt, with a net cash position of $1.03 million or $0.17 per share.
| Cash & Cash Equivalents | 2.24M |
| Total Debt | 1.21M |
| Net Cash | 1.03M |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 32.02M |
| Book Value Per Share | 8.65 |
| Working Capital | -668,000 |
Cash Flow
In the last 12 months, operating cash flow was -$12.34 million and capital expenditures -$72,000, giving a free cash flow of -$12.41 million.
| Operating Cash Flow | -12.34M |
| Capital Expenditures | -72,000 |
| Depreciation & Amortization | 1.10M |
| Net Borrowing | -2.47M |
| Free Cash Flow | -12.41M |
| FCF Per Share | -$2.04 |
Margins
| Gross Margin | -12.43% |
| Operating Margin | -623.29% |
| Pretax Margin | -936.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENvue Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3,835.78% |
| Shareholder Yield | -3,835.78% |
| Earnings Yield | -708.83% |
| FCF Yield | -234.48% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 12, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Aug 12, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ENvue Medical has an Altman Z-Score of -4.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.75 |
| Piotroski F-Score | 2 |